Who makes oral Danshu capsule?

oral Danshu capsule is developed by First People's Hospital of Hangzhou.

What development phase is oral Danshu capsule in?

oral Danshu capsule is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

oral Danshu capsule

First People's Hospital of Hangzhou · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	oral Danshu capsule
Sponsor	First People's Hospital of Hangzhou
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis (PHASE4)
Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

oral Danshu capsule CI brief — competitive landscape report
oral Danshu capsule updates RSS · CI watch RSS
First People's Hospital of Hangzhou portfolio CI